Abstract
Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial.
James Cheng-Chung Wei, Tsai Wen Chan, Huey-Shyan Lin, Feng Huang and Chan-Te Chou
The Journal of Rheumatology December 2003, 30 (12) 2627-2631;
James Cheng-Chung Wei
Tsai Wen Chan
Huey-Shyan Lin
Feng Huang
In this issue
Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial.
James Cheng-Chung Wei, Tsai Wen Chan, Huey-Shyan Lin, Feng Huang, Chan-Te Chou
The Journal of Rheumatology Dec 2003, 30 (12) 2627-2631;